Citi says CSL's CEO pick brings key strengths

By Reuters News

** Citi says CSL's incoming CEO brings commercial, pipeline development experience

** Australia's CSL CSL.AX appointed Deborah Waterhouse as permanent CEO, effective February 2027, after the bell on Wednesday

** Waterhouse is currently CEO of ViiV Healthcare, a joint venture majority-owned by GSK GSK.L

** Brokerage says Waterhouse's experience running a global business in a competitive HIV market bodes well for CSL

** Citi says its experience with Waterhouse suggests she has been thorough, consistent and has demonstrated sound commercial acumen

** Adds, Waterhouse was widely considered the "other" contender in GSK's recent CEO selection process and has worked across several of the company's businesses

** Citi says it is encouraged by the appointment, citing her track record and history of pipeline architecture

** CSL stock up 13% this year, as of last close

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.